Trusted Resources: Education
Scientific literature and patient education texts
Difficulties Associated With Enzyme Replacement Therapy for Mucopolysaccharidoses
source: Turkish archives of pediatrics
year: 2021
authors: Yıldız Y,Sivri HS
summary/abstract:Mucopolysaccharidoses are extremely rare, progressive, often severe multisystem disorders, some of which are managed by weekly intravenous enzyme replacement therapy. This study aimed to determine the difficulties faced by the patients with mucopolysaccharidosis and their families due to enzyme replacement therapy.
organization: Division of Pediatric Metabolism, Department of Pediatrics, Hacettepe University School of Medicine, Ankara, Turkey.DOI: 10.5152/TurkArchPediatr.2021.21235
read more
BookmarkRelated Content
-
Enzyme Replacement Therapy With Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis o...Enzyme replacement therapy (ERT) improve...
-
Expanding the Phenotype of Mucopolysaccharidosis Type II RetinopathyPurpose: To report novel retinal finding...
-
Progression of Cardiovascular Manifestations in Adults and Children With Mucopolysaccharidoses With and Without Enzy...Cardiovascular involvement is among the ...
-
Real-World Data Assessment of Safety of Home-Based and Hospital/Outpatient-Based laronidase Enzyme Replacement Thera...Enzyme replacement therapy (ERT) is avai...
-
The First Mucopolysaccharidosis Type VII in a Taiwanese Girl: A Case Report and Review of the LiteratureThe present study included the first cas...
-
Patricia Dickson, MDDr. Dickson is Division Chief of Genetic...
-
Clinical Utility of Elosulfase Alfa in the Treatment of Morquio A SyndromeMucopolysaccharidosis type IVA (MPS IVA ...
Powered by
